Regeneron Posts Better-Than-Expected Third-Quarter Earnings

Regeneron Posts Better-Than-Expected Third-Quarter Earnings

Source: 
TheStreet.com
snippet: 

Regeneron, one of many pharmaceutical companies deep in the race for a viable Covid-19 vaccine, posts better-than-expected third-quarter earnings and revenue.